Suzy Madar

Partner

Posts From This Author

Federal Court upholds TGA decision to refuse access to documents relating to applications to list generics on the ARTG

Federal Court upholds TGA decision to refuse access to documents relating to applications to list generics on the ARTG

11 February 2011
By Suzy Madar
In December last year, Justice Emmett of the Federal Court handed down an important decision for originator pharmaceutical companies who seek access to documents evidencing applications to list generic versions of their products on the Australian Register of Therapeutic Goods (ARTG), and generic companies who assume such applications are kept confidential. 
Read on
US Court of Appeals for the Second Circuit invites examination of reverse settlement agreements by the Full Court of Appeals

US Court of Appeals for the Second Circuit invites examination of reverse settlement agreements by the Full Court of Appeals

9 June 2010
By Suzy Madar
Further to our 18 May post in relation to the FTC’s anti-trust case against Cephalon concerning the reverse settlement of a patent dispute over Provigil, a US Court of Appeals has taken the unusual step of inviting a petition to the Full Court of Appeals to consider the “difficult questions at issue and the important interests at stake” when considering reverse settlement agreements. 
Read on
BREAKING NEWS: Court finds Vioxx doubled risk of heart attack

BREAKING NEWS: Court finds Vioxx doubled risk of heart attack

5 March 2010
By Suzy Madar
The Federal Court has handed down its findings in the case brought by class action representative Mr Graeme Peterson against Merck Sharpe & Dohme in which it was alleged that Vioxx contributed to Mr Peterson’s heart attack, and that Merck had intentionally downplayed the cardiovascular risks which were associated with the drug. 
Read on
Load More Posts